Surgical Science Sweden AB (publ) (SUSRF)
OTCMKTS
· Delayed Price · Currency is USD
12.62
+1.08 (9.36%)
At close: Apr 16, 2025
SUSRF Revenue
In the year 2024, Surgical Science Sweden AB had annual revenue of 884.09M SEK with 0.14% growth. Surgical Science Sweden AB had revenue of 251.55M in the quarter ending December 31, 2024, with 10.67% growth.
Revenue
884.09M SEK
Revenue Growth
+0.14%
P/S Ratio
8.95
Revenue / Employee
3.23M SEK
Employees
274
Market Cap
714.78M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 884.09M | 1.23M | 0.14% |
Dec 31, 2023 | 882.85M | 80.31M | 10.01% |
Dec 31, 2022 | 802.54M | 435.76M | 118.81% |
Dec 31, 2021 | 366.78M | 261.98M | 249.98% |
Dec 31, 2020 | 104.80M | 3.28M | 3.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |